The Asia Pacific Companion Animal Diagnostics Market is projected to grow significantly, reaching an estimated US$ 1,653.5 million by 2031, up from US$ 840.0 million in 2024. This growth represents a compound annual growth rate (CAGR) of 10.2% from 2025 to 2031. The market encompasses various countries, including China, Japan, India, South Korea, Australia, and other regions within the Asia Pacific.
Key players in this market include IDEXX and Zoetis, which command substantial market shares. These companies are actively pursuing strategic initiatives such as launching new products, expanding into new geographical areas, and engaging in mergers and acquisitions to enhance their competitive positions.
As veterinary specialization continues to develop in the Asia Pacific region, pet owners are gaining better access to specialized diagnostic services. This trend is leading to the establishment of specialized veterinary clinics and the availability of board-certified specialists, which significantly improves the quality of care for companion animals. The rise in veterinary specialization is also fostering educational opportunities for veterinarians, encouraging a culture of continuous learning and expertise in animal health.
There is a growing awareness of animal health among pet owners in the Asia Pacific. As understanding increases regarding the importance of preventive care, early disease detection, and timely treatment, pet owners are increasingly seeking reliable diagnostic tests to monitor their animals' health. This demand is reflected across various medical fields, including emergency medicine, nursing, and surgery.
The Asia Pacific Companion Animal Diagnostics Market is segmented by product, companion animal type, technology, application, and end users. In terms of product, the market is divided into consumables and instruments, with consumables holding the largest share in 2024. By companion animal type, dogs dominate the market, while the technology segment includes immunodiagnostics, molecular diagnostics, clinical biochemistry, hematology, urinalysis, and others, with immunodiagnostics leading in market share. The application segment is categorized into clinical pathology, bacteriology, parasitology, virology, and others, with clinical pathology being the largest segment. Finally, the end-user segment includes diagnostic and reference laboratories, veterinary hospitals and clinics, research institutes, and others, with veterinary hospitals and clinics holding the largest share.
The humanization of pets is a significant trend reshaping the veterinary healthcare landscape. Pet owners are increasingly willing to invest in their pets' health, driving demand for accurate and minimally invasive diagnostic solutions. The rise in pet ownership, particularly during the COVID-19 pandemic, has led to increased expenditure on healthcare services for pets. Reports indicate that millions of pets were adopted during lockdowns, with families in the US, EU, and China adopting over half a billion dogs and cats. This trend is further supported by demographic changes, rising income levels, and a growing awareness of the importance of pet insurance, which protects against escalating veterinary treatment costs.
In well-developed economies, pet owners are more proactive about their pets' health, often opting for diagnostic testing despite potential costs. This trend is particularly evident in point-of-care (POC) diagnostics, which provide rapid results and facilitate early detection of health issues during routine veterinary visits. As a result, the demand for veterinary POC diagnostic tools is expected to rise, driven by the increasing humanization of pets and the growing number of pet owners.
Country-wise, the Asia Pacific Companion Animal Diagnostics Market is dominated by China, which held the largest market share in 2024. The pet population in China is expanding, leading to a heightened demand for veterinary services, including diagnostics. With a significant number of households owning pets, there is a growing concern among pet owners regarding the health and nutrition of their animals. Recent statistics indicate that there were approximately 112.3 million urban dogs in China in 2021, reflecting an 11.4% increase from the previous year. The market's growth in China is supported by government initiatives aimed at enhancing veterinary medicine, technological advancements, and the increasing adoption of pets.
In January 2024, Zoetis Inc. expanded its Vetscan Imagyst platform to include AI-driven urine sediment analysis, which allows for quick and accurate in-clinic analysis, enabling personalized treatment plans for pets. This innovation exemplifies the technological advancements that are shaping the companion animal diagnostics market in China.
Overall, the Asia Pacific Companion Animal Diagnostics Market is poised for substantial growth, driven by increasing pet ownership, heightened awareness of animal health, and advancements in veterinary diagnostics.
Key players in this market include IDEXX and Zoetis, which command substantial market shares. These companies are actively pursuing strategic initiatives such as launching new products, expanding into new geographical areas, and engaging in mergers and acquisitions to enhance their competitive positions.
As veterinary specialization continues to develop in the Asia Pacific region, pet owners are gaining better access to specialized diagnostic services. This trend is leading to the establishment of specialized veterinary clinics and the availability of board-certified specialists, which significantly improves the quality of care for companion animals. The rise in veterinary specialization is also fostering educational opportunities for veterinarians, encouraging a culture of continuous learning and expertise in animal health.
There is a growing awareness of animal health among pet owners in the Asia Pacific. As understanding increases regarding the importance of preventive care, early disease detection, and timely treatment, pet owners are increasingly seeking reliable diagnostic tests to monitor their animals' health. This demand is reflected across various medical fields, including emergency medicine, nursing, and surgery.
The Asia Pacific Companion Animal Diagnostics Market is segmented by product, companion animal type, technology, application, and end users. In terms of product, the market is divided into consumables and instruments, with consumables holding the largest share in 2024. By companion animal type, dogs dominate the market, while the technology segment includes immunodiagnostics, molecular diagnostics, clinical biochemistry, hematology, urinalysis, and others, with immunodiagnostics leading in market share. The application segment is categorized into clinical pathology, bacteriology, parasitology, virology, and others, with clinical pathology being the largest segment. Finally, the end-user segment includes diagnostic and reference laboratories, veterinary hospitals and clinics, research institutes, and others, with veterinary hospitals and clinics holding the largest share.
The humanization of pets is a significant trend reshaping the veterinary healthcare landscape. Pet owners are increasingly willing to invest in their pets' health, driving demand for accurate and minimally invasive diagnostic solutions. The rise in pet ownership, particularly during the COVID-19 pandemic, has led to increased expenditure on healthcare services for pets. Reports indicate that millions of pets were adopted during lockdowns, with families in the US, EU, and China adopting over half a billion dogs and cats. This trend is further supported by demographic changes, rising income levels, and a growing awareness of the importance of pet insurance, which protects against escalating veterinary treatment costs.
In well-developed economies, pet owners are more proactive about their pets' health, often opting for diagnostic testing despite potential costs. This trend is particularly evident in point-of-care (POC) diagnostics, which provide rapid results and facilitate early detection of health issues during routine veterinary visits. As a result, the demand for veterinary POC diagnostic tools is expected to rise, driven by the increasing humanization of pets and the growing number of pet owners.
Country-wise, the Asia Pacific Companion Animal Diagnostics Market is dominated by China, which held the largest market share in 2024. The pet population in China is expanding, leading to a heightened demand for veterinary services, including diagnostics. With a significant number of households owning pets, there is a growing concern among pet owners regarding the health and nutrition of their animals. Recent statistics indicate that there were approximately 112.3 million urban dogs in China in 2021, reflecting an 11.4% increase from the previous year. The market's growth in China is supported by government initiatives aimed at enhancing veterinary medicine, technological advancements, and the increasing adoption of pets.
In January 2024, Zoetis Inc. expanded its Vetscan Imagyst platform to include AI-driven urine sediment analysis, which allows for quick and accurate in-clinic analysis, enabling personalized treatment plans for pets. This innovation exemplifies the technological advancements that are shaping the companion animal diagnostics market in China.
Overall, the Asia Pacific Companion Animal Diagnostics Market is poised for substantial growth, driven by increasing pet ownership, heightened awareness of animal health, and advancements in veterinary diagnostics.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Companion Animal Diagnostics Market - Key Market Dynamics
5. Companion Animal Diagnostics Market - Asia Pacific Market Analysis
6. Asia Pacific Companion Animal Diagnostics Market Revenue Analysis - by Product
7. Asia Pacific Companion Animal Diagnostics Market Revenue Analysis - by Companion Animal
8. Asia Pacific Companion Animal Diagnostics Market Revenue Analysis - by Technology
9. Asia Pacific Companion Animal Diagnostics Market Revenue Analysis - by Application
10. Asia Pacific Companion Animal Diagnostics Market Revenue Analysis - by End Users
11. Asia Pacific Companion Animal Diagnostics Market - Country Analysis
12 Competitive Landscape
13 Industry Landscape
15 COMPANY PROFILES
15. Appendix
LIST OF TABLES
LIST OF FIGURES
Companies
The List of Companies - Asia Pacific Companion Animal Diagnostics MarketZoetis Inc
Idexx Laboratories Inc
Innovative Diagnostics SAS
Tianjin LOCMEDT Technologies Co Ltd
ARI Medical Technology Co Ltd
Demeditec Diagnostics GmbH
